Related Experiment Video
Updated: Jun 12, 2025
13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.5K
What every clinician should know about inflammation in COPD
Michael E Wechsler1, J Michael Wells2
1Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, CO, USA.
ERJ Open Research
|September 25, 2024
Summary
Inflammation is central to Chronic Obstructive Pulmonary Disease (COPD) development and worsening. Understanding cellular interactions and patient-specific factors guides precision medicine and informs new anti-inflammatory treatments for COPD.
Area of Science:
- Pulmonology
- Immunology
- Pharmacology
Background:
- Inflammation is a key driver of Chronic Obstructive Pulmonary Disease (COPD) pathogenesis and exacerbations.
- While major inflammatory pathways in COPD are known, cellular interactions and etiological factors causing heterogeneity are still being uncovered.
- This evolving understanding supports a move towards precision medicine in COPD management.
Purpose of the Study:
- To review the inflammatory processes involved in COPD.
- To connect inflammation with pathological and functional changes in COPD.
- To discuss patient-specific factors influencing COPD and current/emerging anti-inflammatory treatments.
Main Methods:
- Literature review of inflammatory processes in COPD.
- Analysis of cellular interactions and etiological differences.
- Synthesis of data on patient-specific factors and treatment responses.
Main Results:
- Detailed description of inflammatory mechanisms in COPD.
- Identification of factors contributing to heterogeneous inflammatory profiles.
- Overview of current and novel anti-inflammatory therapies, including biologics and PDE inhibitors.
Conclusions:
- Inflammation's role in COPD is complex and heterogeneous.
- Understanding these nuances is crucial for developing targeted therapies.
- Precision medicine approaches are advancing COPD treatment through tailored anti-inflammatory strategies.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:20COPD: Pathogenesis and Clinical Features
243
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
243
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
186
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
186
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K